Does baseline HbA1c or change in HbA1c predict the reduction in cardiovascular death with empagliflozin? Results from EMPA-REG OUTCOME

被引：0
|
作者：
Inzucchi, S. E. [1 ]
Fitchett, D. [2 ]
Wanner, C. [3 ]
Mattheus, M. [4 ]
George, J. T. [4 ]
Woerle, H. J. [4 ]
Zinman, B. [5 ]
机构：
[1] Yale Univ, Sch Med, Sect Endocrinol, New Haven, CT USA
[2] Univ Toronto, St Michaels Hosp, Div Cardiol, Toronto, ON, Canada
[3] Wurzburg Univ Clin, Dept Med, Wurzburg, Germany
[4] Boehringer Ingelheim Pharma GmbH & Co KG, Therapeut Area Metab, Ingelheim, Germany
[5] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada
来源：
DIABETIC MEDICINE | 2018年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A18
引用
收藏
页码：11 / 11
页数：1
相关论文
共 50 条
  • [41] Change in HbA1c post-transfusion is correlated to pre-transfusion HbA1c result
    Kroner, Grace
    Jones, Andrew
    Bena, James
    Morrison, Shannon
    Bakdash, Suzanne
    Colon-Franco, Jessica
    Reineks, Edmunds
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2023, 160 : S130 - S131
  • [42] Change in HbA1c post-transfusion is correlated to pre-transfusion HbA1c result
    Kroner, Grace
    Jones, Andrew
    Bena, James
    Morrison, Shannon
    Bakdash, Suzanne
    Colon-Franco, Jessica
    Reineks, Edmunds
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2023, 160 : S130 - S131
  • [43] Prediction of diabetes mellitus using HbA1c: Does HbA1c more efficiently predict onset than plasma glucose concentration?
    Tanabe, N.
    Yamamoto, M.
    Momotsu, T.
    Suzuki, K.
    Sanpei, K.
    Sone, H.
    DIABETOLOGIA, 2013, 56 : S122 - S122
  • [44] Semaglutide reduces HbA1c across baseline HbA1c subgroups across SUSTAIN 1-5 clinical trials
    Bain, S. C.
    Araki, E.
    DeSouza, C.
    Garg, S.
    Rose, L.
    Tsoukas, G.
    Bergan, E. Q.
    Karsbol, J. D.
    DeVries, J. H.
    DIABETIC MEDICINE, 2018, 35 : 81 - 81
  • [45] Semaglutide Reduces HbA1c across Baseline HbA1c Subgroups across SUSTAIN 1-5 Clinical Trials
    Bain, Stephen
    Araki, Eiichi
    Desouza, Cyrus
    Garg, Satish
    Rose, Ludger
    Tsoukas, George
    Bergan, Eirik Q.
    Karsbol, Julie Derving
    Devries, J. Hans
    DIABETES, 2017, 66 : A298 - A299
  • [46] The interference by HbF on HbA1c (BM Test HbA1c) measurement in enzymatic method
    Nitta, Takenori
    Yamashiro, Yasuhiro
    Hattori, Yukio
    Ezumi, Tomoko
    Nishioka, Mituaki
    Nakamura, Junji
    ANNALS OF CLINICAL BIOCHEMISTRY, 2015, 52 (05) : 569 - 575
  • [47] How does CKD affect HbA1c?
    Bloomgarden, Zachary
    Handelsman, Yehuda
    JOURNAL OF DIABETES, 2018, 10 (04) : 270 - 270
  • [48] The True Value of HbA1c as a Predictor of Diabetic Complications: Simulations of HbA1c Variables
    Lind, Marcus
    Oden, Anders
    Fahlen, Martin
    Eliasson, Bjorn
    PLOS ONE, 2009, 4 (02):
  • [49] HbA1c and Glucose Management Indicator relationship: can HbA1c determination be avoided?
    Navarro Moreno, Constanza
    Sanchez Ruiz, Daniel
    Garcia Garcia, Emilio Jose
    Marchueta Elizagarate, Izaskun
    Gomez Gila, Ana Lucia
    HORMONE RESEARCH IN PAEDIATRICS, 2021, 94 (SUPPL 1): : 234 - 235
  • [50] Use of labile HbA1c as a screening tool to minimize clinical misinterpration of HbA1c
    De Muynck, Emilie
    Lapauw, Bruno
    Delanghe, Joris
    Lambrecht, Stijn
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2024,
12345